|
RTTN expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.916100E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.800800E-01 |
| Normal-vs-Stage2 |
4.090400E-01 |
| Normal-vs-Stage3 |
2.139000E-01 |
| Normal-vs-Stage4 |
2.447900E-02 |
| Stage1-vs-Stage2 |
8.101400E-01 |
| Stage1-vs-Stage3 |
5.110200E-01 |
| Stage1-vs-Stage4 |
7.253900E-02 |
| Stage2-vs-Stage3 |
7.223000E-01 |
| Stage2-vs-Stage4 |
1.465600E-01 |
| Stage3-vs-Stage4 |
2.400400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.360000E-01 |
| Normal-vs-AfricanAmerican |
5.759800E-02 |
| Normal-vs-Asian |
3.136800E-01 |
| Caucasian-vs-AfricanAmerican |
9.714100E-02 |
| Caucasian-vs-Asian |
3.323600E-01 |
| AfricanAmerican-vs-Asian |
4.867000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.308600E-01 |
| Normal-vs-Female |
1.528150E-02 |
| Male-vs-Female |
6.331600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.361600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.082250E-01 |
| Normal-vs-Age(61-80Yrs) |
1.018570E-01 |
| Normal-vs-Age(81-100Yrs) |
1.089810E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.045800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.862800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.913000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.754800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.938200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.020400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
2.398800E-01 |
| Normal-vs-Grade 2 |
2.287200E-01 |
| Normal-vs-Grade 3 |
1.872350E-01 |
| Normal-vs-Grade 4 |
1.064020E-01 |
| Grade 1-vs-Grade 2 |
3.071800E-01 |
| Grade 1-vs-Grade 3 |
3.328400E-01 |
| Grade 1-vs-Grade 4 |
7.476600E-01 |
| Grade 2-vs-Grade 3 |
7.683400E-01 |
| Grade 2-vs-Grade 4 |
1.992390E-01 |
| Grade 3-vs-Grade 4 |
2.443200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
2.598800E-03 |
| Normal-vs-ccB subtype |
2.396000E-01 |
| ccA subtype-vs-ccB subtype |
1.781270E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.375800E-01 |
| Normal-vs-N1 |
2.730600E-01 |
| N0-vs-N1 |
3.378000E-01 |
|
|
